“In 2009, Sanofi-Aventis shelved its plan to develop eplivanserin, a serotonin antagonist.”
“In some positive news for its R&D, Sanofi said its experimental insomnia treatment eplivanserin performed significantly better than a placebo pill in a large clinical trial.”
“Nano drug ALX-0081 from Ablynx to open up blocked blood vessels coming Non opium pain drug tezampanel can treat acute migraine, says Raptor GlaxoSmithKline withdraws Zunrisa (casopitant) filings on safety fears Drug to improve cognition in Alzheimer's patients Lu AE58054 in human studies: Lundbeck US FDA seeks more data on Sanofi-Aventis sleep drug eplivanserin (Ciltyril)”
“The US Food and Drug Administration or FDA, in September rejected eplivanserin, saying additional information about benefits and risks would be needed before approval.”
‘eplivanserin’ hasn't been added to any lists yet.
Looking for tweets for eplivanserin.